Our Services
Comprehensive biotech analysis and investor relations solutions
Direct-to-Investor Platform
Data-driven platform connecting life sciences companies with investors, enhancing brand awareness and facilitating direct engagement beyond traditional channels.
Equity Research & Analysis
In-depth equity research across therapeutic areas including oncology, gene therapy, neurodegenerative diseases, and more—delivered through written analysis and media commentary.
Educational Media Platform
YouTube videos, podcasts, and broadcast content breaking down complex biotech topics, company valuations, clinical trials, and therapeutic innovations for all audiences.
Consulting & IR Support
Executive consulting, digital marketing, and investor relations assistance tailored for biotech companies seeking to enhance their market presence and investor engagement.
Featured Videos
Watch our latest biotech company interviews and analysis
TuHURA Full Length
In-depth conversation with TuHURA Biosciences CEO Dr. James Bianco discussing the company's innovative approach to cancer immunotherapy, their Delta Opioid Receptor (DOR) platform, and clinical pipeline targeting tumor-associated macrophages.
China's Role in Drug Development
China and the US
Vaccine Distribution
Conversation with Trinity Capital's Life Science Lead Rob Lake #1
Conversation with Trinity Capital's Life Science Lead Rob Lake #2
Our Partners
Leading biotech companies we work with
About Unboxing Biotech
John D. Vandermosten, CFA
Senior Biotechnology Analyst
With over 20 years of experience in biotechnology equity research and investment analysis, John brings deep expertise in evaluating life sciences companies across multiple therapeutic areas. His work bridges the gap between complex scientific innovation and investment strategy, helping investors make informed decisions in the rapidly evolving biotech sector.
Areas of Coverage
Get In Touch
Have questions? We'd love to hear from you.